Journal of the National Cancer Institute Advance Access originally published online on May 13, 2008
JNCI Journal of the National Cancer Institute 2008 100(10):690-691; doi:10.1093/jnci/djn170
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2008.
NEWS |
Lung Cancer Screening Trial Financed by Tobacco-Funded Foundation, Sparks Debate
| The first 150 words of the full text of this article appear below. |
For those who are worried about conflicts of interest in medical research, the news that a cigarette company helped fund a major lung cancer screening study, revealed in a front page story in the New York Times and in the Cancer Letter, represented a perfect storm of ethical issues that could further erode public confidence in the value of academic science.
The story highlighted how two discrete issues that research institutions grapple with—financial conflict of interest and use of tobacco company money to fund research—came together in a highly unusual way, complicating the interpretation of results from internationally known researchers and a major medical institution.
The Times and the Cancer Letter reported that Weill Cornell Medical College researchers Claudia Henschke, M.D., Ph.D., and David Yankelevitz, M.D., its dean, Antonio Gotto, M.D., D.Phil., and the vice chairman of the college board of overseers, Arthur J. Mahon, were officers of a
Angry Reactions
Foundations Need Scrutiny
Institutional Policies